FGF21-FGFR4 signaling in cardiac myocytes promotes concentric cardiac hypertrophy in mouse models of diabetes

Abstract Fibroblast growth factor (FGF) 21, a hormone that increases insulin sensitivity, has shown promise as a therapeutic agent to improve metabolic dysregulation. Here we report that FGF21 directly targets cardiac myocytes by binding β-klotho and FGF receptor (FGFR) 4. In combination with high g...

詳細記述

書誌詳細

主要な著者:	Christopher Yanucil, Dominik Kentrup, Xueyi Li, Alexander Grabner, Karla Schramm, Eliana C. Martinez, Jinliang Li, Isaac Campos, Brian Czaya, Kylie Heitman, David Westbrook, Adam R. Wende, Alexis Sloan, Johanna M. Roche, Alessia Fornoni, Michael S. Kapiloff, Christian Faul
フォーマット:	Artigo
言語:	Inglês
出版事項:	Nature Portfolio 2022-05-01
シリーズ:	Scientific Reports
オンライン･アクセス:	https://doi.org/10.1038/s41598-022-11033-x
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!